| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139; and
Department of Pathology, Harvard Medical School, Boston, MA 02115
We describe a role for myeloid differentiation factor 88 (MyD88) in the induction of functional CTLs in vivo, in response to exogenously administered Ag, using a heat shock fusion protein, hsp65-P1, as a model Ag. CD8 T cells transferred into MyD88-deficient animals produce normal numbers of CD8 effector cells that have normal activation marker profiles after immunization with hsp65-P1. However, these CD8 T cells produced significantly less IFN-
and showed reduced killing activity. This reduction in activation of functional CTLs appears to be unrelated to Toll-like receptor 4 function, because in vitro hsp65-P1-experienced Toll-like receptor 4-deficient dendritic cells (DCs), but not MyD88-deficient DCs, activated CD8 T cells to a similar extent to wild-type DCs. We identify a cross-presentation defect in MyD88-deficient DCs that, when treated with hsp65-P1 fusion protein, results in surface display of fewer SIYRYYGL/class I MHC complexes. Thus, MyD88 plays a role in the developmental maturation of DCs that allows them to prime CD8 T cells through cross-presentation.
This article has been cited by other articles:
|
|
 |
|
  M. Holcmann, P. Stoitzner, B. Drobits, P. Luehrs, G. Stingl, N. Romani, D. Maurer, and M. Sibilia Skin Inflammation Is Not Sufficient to Break Tolerance Induced against a Novel Antigen J. Immunol., July 15, 2009; 183(2): 1133 - 1143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Zhou, E. A. Kurt-Jones, A. M. Cerny, M. Chan, R. T. Bronson, and R. W. Finberg MyD88 Intrinsically Regulates CD4 T-Cell Responses J. Virol., February 15, 2009; 83(4): 1625 - 1634. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J M. Blander Phagocytosis and antigen presentation: a partnership initiated by Toll-like receptors Ann Rheum Dis, December 1, 2008; 67(Suppl_3): iii44 - iii49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Zhou, E. A. Kurt-Jones, K. A. Fitzgerald, J. P. Wang, A. M. Cerny, M. Chan, and R. W. Finberg Role of MyD88 in Route-Dependent Susceptibility to Vesicular Stomatitis Virus Infection J. Immunol., April 15, 2007; 178(8): 5173 - 5181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Takeshita, T. Tanaka, T. Matsuda, M. Tozuka, K. Kobiyama, S. Saha, K. Matsui, K. J. Ishii, C. Coban, S. Akira, et al. Toll-Like Receptor Adaptor Molecules Enhance DNA-Raised Adaptive Immune Responses against Influenza and Tumors through Activation of Innate Immunity. J. Virol., July 1, 2006; 80(13): 6218 - 6224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chen, C. Barnfield, T. I. Naslund, M. N. Fleeton, and P. Liljestrom MyD88 Expression Is Required for Efficient Cross-Presentation of Viral Antigens from Infected Cells J. Virol., March 1, 2005; 79(5): 2964 - 2972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E. Hamilton-Williams, A. Lang, D. Benke, G. M. Davey, K.-H. Wiesmuller, and C. Kurts Cutting Edge: TLR Ligands Are Not Sufficient to Break Cross-Tolerance to Self-Antigens J. Immunol., February 1, 2005; 174(3): 1159 - 1163. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
